Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Mini-Reviews in Medicinal Chemistry

Bruton’s Tyrosine Kinase Inhibitors: A Versatile Therapeutic Approach for Cancer, Autoimmune Disorders, GVHD, and COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSwati PaliwalUAUma AgarwalRTRajiv Kumar Tonk

Discussion

Loading...

Member takes

Overview

Literature analysis reports on BTK inhibitors improving treatment in cancer and autoimmune disorders, suggesting potential in COVID-19.

Key Points

  • BTK inhibition has emerged as a promising approach to treat multiple diseases, enhancing immune response regulation.
  • Evidence indicates BTK inhibitors can effectively target BCR signaling, providing better therapeutic outcomes compared to traditional therapies.
  • Observational analysis discusses pharmacological mechanisms that guide the use of combination therapies with BTK inhibitors for patient-specific needs.
  • This review highlights the significance of BTK inhibitors in addressing serious conditions including autoimmune disorders and COVID-19, emphasizing ongoing development.

Cite This Study

Paliwal et al. (2025) studied this question.

synapsesocial.com/papers/68c1925e9b7b07f3a061738ahttps://doi.org/10.2174/0113895575409452250815095743
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bruton's Tyrosine Kinase: Pathophysiological Roles and Inhibitor‐Based Therapeutic Advances2026
  2. 2Bruton’s Tyrosine Kinase Inhibitors: Recent Updates2024 · 35 citations
  3. 3Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton’s Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation2026
  4. 4Bruton’s tyrosine kinase (BTK) inhibitors: an updated patent review (2019-2024)2025
  5. 5Bruton's Tyrosine Kinase-Going Beyond the B Cell.2026 · 1 citations